Nanotechnology constitutes a great promise for domains as diverse as product development, environmental conservation, medicine and information technology while simultaneously giving rise to numerous concerns about potential health risks and environmental hazards. In addition, nanotechnology raises wider social and ethical issues regarding unintended long-term consequences, social and financial risks, issues of governance and control and fundamental issues about life and human identity.
The California NanoSystems Institute (CNSI) is an integrated research facility with locations at UCLA and UC Santa Barbara. Its mission is to encourage university collaboration with industry and to enable the rapid commercialization of discoveries in nanoscience and nannotechnology. CNSI members who are on the faculty at UCLA and UCSB represent a multi-disciplinary team of some of the world's preeminent scientists from the life and physical sciences, engineering, and medicine.
Our research focuses on developing strategic and surface nano-optical methods for controlling the architecture of molecules and materials on a 1-100 nm scale. Our researchers, with backgrounds ranging from medicine, biology, chemistry, physics and material science, are working together in solving fundamental and applied problems of modern nanoscience.
Celgene is a global biopharmaceutical company committed to improving the lives of patients worldwide.
At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our mission as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.
Green Millennium is a photo-catalyst material and solution provider in the domain of environmental coating services and business integration.
Excellin is a privately-held biotechnology company developing an award-winning consumable-driven technology for cell performance optimization in the biopharmaceutical industry.
Eksigent serves the life science, drug discovery and pharmaceutical industries, expanding customer possibilities with low–flow fluid delivery solutions
Crystallume pioneers the development and application of Chemical Vapor Deposition (CVD) diamond technology.
Calando is a clinical stage nanobiotechnology company at the forefront of RNAi therapeutics.